Screening for drug-resistant Candida yeasts with chromogenic agar

References

• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 3rd. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Villanova, PA, 2008.
   Google Scholar
• Alexander BD, Byrne TC, Smith KL, . Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007; 45: 698–706.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Hollis RJ, . Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posa-conazole. J Clin Microbiol 2007; 45: 1974–1977.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Kirkpatrick WR, Revankar SG, . Comparative evaluation of macrodilution and chromogenic agar screening for fu-conazole susceptibility of Candida albicans. J Clin Microbiol 1996; 34: 3237–3239.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Revankar SG, Kirkpatrick WR, . Simple method for detecting fuconazole-resistant yeasts with chromogenic agar. J Clin Microbiol 1996; 34: 1794–1797.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, . In vitro activities of anidu-lafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fuconazole. J Clin Microbiol 2005; 43: 5425–5427.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Rex JH, . Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microb 2006; 44: 819–826.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, . In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 2008; 46: 150–156.
   PubMed Web of Science ®Google Scholar
• Redding SW, Marr KA, Kirkpatrick WR, . Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation. Med Mycol 2004; 42: 479–481.
   PubMed Web of Science ®Google Scholar
• Redding SW, Zellars RC, Kirkpatrick WR, . Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 1999; 37: 3896–3900.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Spreghini E, Tomassetti S, . Comparison of the fun-gicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob Agents Chemother 2005; 49: 4989–4992.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Nivoix Y, Fohrer C, . Management of systemic fungal infections: alternatives to itraconazole. J Antimicrob Chemother 2005; 56(Suppl. 1): i39–i48
   Google Scholar
• Zaoutis TE, Foraker E, McGowan KL, . Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagn Microbiol Infect Dis 2005; 52: 295–298.
   PubMed Web of Science ®Google Scholar
• Brockway EB, Coco J, Kirkpatrick WR, . Screening for Candida glabrata susceptibility using CHROMagar Candida containing fuconazole. Abstr. C-135. P. 120. Abstract 102nd General Meeting American Society for Microbiology, 2002, Salt Lake City, UT.
   Google Scholar
• Cantón E, Pemán J, Espinel-Ingroff A, . Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts. J Antimicrob Chemother 2008; 61: 135–138.
   Google Scholar
• Espinel-Ingroff A, Cantón E. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of flamentous fungi with ampho-tericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2008; 46: 1793–1803.
   PubMed Web of Science ®Google Scholar
• Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol 2007; 45: 569–587.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Lortholary O, Raoux D, . Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005–2006. Antimicrob Agents Chemother 2008; 52: 778–781.
   PubMed Web of Science ®Google Scholar
• Redding SW, Dahiya MC, Kirkpatrick WR, . Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 47–52.
   PubMed Web of Science ®Google Scholar
• Westbrook SD, Kirkpatrick WR, Freytes CO, . Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient. Med Mycol 2007; 45: 187–190.
   PubMed Web of Science ®Google Scholar
• Thompson GR 3rd, Wiederhold NP, Vallor AC, . Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother 2008; 52: 3783–3785.
   PubMed Web of Science ®Google Scholar